Format
Items per page
Sort by

Send to:

Choose Destination

Results: 20

Related Articles by Review for PubMed (Select 20548297)

1.

Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology.

Bangasser DA, Curtis A, Reyes BA, Bethea TT, Parastatidis I, Ischiropoulos H, Van Bockstaele EJ, Valentino RJ.

Mol Psychiatry. 2010 Sep;15(9):877, 896-904. doi: 10.1038/mp.2010.66. Epub 2010 Jun 15.

2.

Sex differences in molecular and cellular substrates of stress.

Bangasser DA, Valentino RJ.

Cell Mol Neurobiol. 2012 Jul;32(5):709-23. doi: 10.1007/s10571-012-9824-4. Epub 2012 Apr 10. Review.

3.

Sex-biased stress signaling: the corticotropin-releasing factor receptor as a model.

Valentino RJ, Bangasser D, Van Bockstaele EJ.

Mol Pharmacol. 2013 Apr;83(4):737-45. doi: 10.1124/mol.112.083550. Epub 2012 Dec 13. Review.

4.

Sex-specific cell signaling: the corticotropin-releasing factor receptor model.

Valentino RJ, Van Bockstaele E, Bangasser D.

Trends Pharmacol Sci. 2013 Aug;34(8):437-44. doi: 10.1016/j.tips.2013.06.004. Epub 2013 Jul 11. Review.

5.

Using high resolution imaging to determine trafficking of corticotropin-releasing factor receptors in noradrenergic neurons of the rat locus coeruleus.

Reyes BA, Bangasser DA, Valentino RJ, Van Bockstaele EJ.

Life Sci. 2014 Sep 1;112(1-2):2-9. doi: 10.1016/j.lfs.2014.07.017. Epub 2014 Jul 21. Review.

PMID:
25058917
6.

Molecular and cellular sex differences at the intersection of stress and arousal.

Valentino RJ, Reyes B, Van Bockstaele E, Bangasser D.

Neuropharmacology. 2012 Jan;62(1):13-20. doi: 10.1016/j.neuropharm.2011.06.004. Epub 2011 Jun 21. Review.

8.

Corticotropin releasing factor (CRF) receptor signaling in the central nervous system: new molecular targets.

Hauger RL, Risbrough V, Brauns O, Dautzenberg FM.

CNS Neurol Disord Drug Targets. 2006 Aug;5(4):453-79. Review.

9.

Opposing regulation of the locus coeruleus by corticotropin-releasing factor and opioids. Potential for reciprocal interactions between stress and opioid sensitivity.

Valentino RJ, Van Bockstaele E.

Psychopharmacology (Berl). 2001 Dec;158(4):331-42. Epub 2001 Mar 14. Review.

PMID:
11797054
10.

Role of CRF receptor signaling in stress vulnerability, anxiety, and depression.

Hauger RL, Risbrough V, Oakley RH, Olivares-Reyes JA, Dautzenberg FM.

Ann N Y Acad Sci. 2009 Oct;1179:120-43. doi: 10.1111/j.1749-6632.2009.05011.x. Review.

11.

Therapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: evidence from animal models.

Kehne JH, Cain CK.

Pharmacol Ther. 2010 Dec;128(3):460-87. doi: 10.1016/j.pharmthera.2010.08.011. Epub 2010 Sep 6. Review.

12.
13.

Emerging role of alternative splicing of CRF1 receptor in CRF signaling.

Zmijewski MA, Slominski AT.

Acta Biochim Pol. 2010;57(1):1-13. Epub 2010 Mar 16. Review.

14.

Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy.

Hauger RL, Olivares-Reyes JA, Dautzenberg FM, Lohr JB, Braun S, Oakley RH.

Neuropharmacology. 2012 Feb;62(2):705-14. doi: 10.1016/j.neuropharm.2011.11.007. Epub 2011 Nov 25. Review.

15.

The CRF system, stress, depression and anxiety-insights from human genetic studies.

Binder EB, Nemeroff CB.

Mol Psychiatry. 2010 Jun;15(6):574-88. doi: 10.1038/mp.2009.141. Epub 2009 Dec 15. Review.

16.

Corticotropin-releasing factor signaling and visceral response to stress.

Stengel A, Taché Y.

Exp Biol Med (Maywood). 2010 Oct;235(10):1168-78. doi: 10.1258/ebm.2010.009347. Review.

17.

Stress and visceral pain: from animal models to clinical therapies.

Larauche M, Mulak A, Taché Y.

Exp Neurol. 2012 Jan;233(1):49-67. doi: 10.1016/j.expneurol.2011.04.020. Epub 2011 May 6. Review.

18.

Sex differences in stress-related psychiatric disorders: neurobiological perspectives.

Bangasser DA, Valentino RJ.

Front Neuroendocrinol. 2014 Aug;35(3):303-19. doi: 10.1016/j.yfrne.2014.03.008. Epub 2014 Apr 12. Review.

PMID:
24726661
19.

[Mechanisms of analgesic action of corticotropin-releasing factor on somatic pain sensitivity in rats].

Iarushkina NI, Bagaeva TR, Filaretova LP.

Ross Fiziol Zh Im I M Sechenova. 2013 Jul;99(7):805-19. Review. Russian.

PMID:
25470917
20.

Stress-related modulation of inflammation in experimental models of bowel disease and post-infectious irritable bowel syndrome: role of corticotropin-releasing factor receptors.

Kiank C, Taché Y, Larauche M.

Brain Behav Immun. 2010 Jan;24(1):41-8. doi: 10.1016/j.bbi.2009.08.006. Epub 2009 Aug 19. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk